Weekly injectable medications for type 2 diabetes
Pro Research Analysisby 
Searched over 200M research papers
Weekly Injectable Medications for Type 2 Diabetes: Efficacy, Adherence, and Patient Experience
Once-Weekly GLP-1 Receptor Agonists: Efficacy and Safety
Once-weekly injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide, dulaglutide, and exenatide have become important options for type 2 diabetes management. These medications are effective at lowering blood sugar (HbA1c) and body weight, with studies showing significant reductions in both compared to placebo and daily regimens. For example, once-weekly semaglutide led to a decrease in HbA1c of up to 1.55% and weight loss of up to 4.53 kg over 30 weeks, with most side effects being mild to moderate and mainly gastrointestinal in nature Sorli2017Nauck2020. Similarly, tirzepatide, a dual GIP/GLP-1 agonist, demonstrated greater reductions in HbA1c and body weight compared to daily insulin degludec, with a higher proportion of patients reaching target HbA1c levels and experiencing weight loss .
Once-Weekly Insulin: A New Frontier
Newer basal insulins designed for once-weekly injection, such as insulin icodec, have shown similar glucose-lowering efficacy and safety compared to traditional once-daily insulins like glargine. In both insulin-naive patients and those already on basal-bolus regimens, once-weekly icodec achieved non-inferior reductions in HbA1c, with low rates of hypoglycemia and no new safety concerns Rosenstock2020Mathieu2023Trevisan2024. These findings suggest that weekly insulin could simplify diabetes management and improve quality of life by reducing injection frequency.
Adherence and Persistence: Weekly vs. Daily Injections
Reducing injection frequency from daily to weekly has a clear positive impact on medication adherence and persistence. Studies consistently show that patients on once-weekly GLP-1 RAs are more likely to continue their medication and take it as prescribed compared to those on daily injections. For example, one study found that patients on weekly regimens had a median treatment duration of 333 days versus 269 days for daily regimens, and were 20% less likely to stop treatment early. Better adherence was also linked to greater reductions in blood sugar Weeda2021Polonsky2021. These benefits are seen across different patient populations, including those with more advanced diabetes.
Patient Barriers and Preferences with Weekly Injectables
Despite the advantages, some barriers to injectable therapy remain. Common issues include concerns about injections (needle aversion, pain), cost, and adverse events such as gastrointestinal symptoms. For weekly GLP-1 RAs, injection concerns and side effects are the most frequently cited reasons for discontinuation or delayed initiation . Additionally, small differences in the injection process—such as the need for reconstitution, waiting time, or needle handling—can slightly affect patient quality of life and preferences, though these effects are generally minor .
Clinical Recommendations and Evolving Guidelines
Current guidelines recommend GLP-1 RAs as the preferred first injectable therapy for type 2 diabetes, especially for patients with cardiovascular risk, due to their efficacy in lowering blood sugar and weight, and their cardiovascular benefits. Weekly formulations are particularly favored for their convenience and potential to improve adherence. Weekly insulins are emerging as a promising option for patients who require basal insulin, offering similar efficacy with fewer injections Nauck2020Trevisan2024.
Conclusion
Weekly injectable medications, including GLP-1 receptor agonists and new basal insulins, offer effective and safe options for managing type 2 diabetes. They improve adherence and persistence compared to daily injections, with the added benefit of weight loss and cardiovascular protection for GLP-1 RAs. While some barriers remain, the reduced injection burden and strong clinical outcomes make weekly injectables an important advancement in diabetes care.
Sources and full results
Most relevant research papers on this topic